Click to Share
 

Gene Therapy Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

12554233
By Saving Case & Friends, Inc.
Efforts Bringing Awareness to Hunter Syndrome Are Recognized by Telly Awards and International Songwriting Competition
12474216
By Project Alive, a campaign of Saving Case & Friends
Parents of children with the rare disease Hunter Syndrome launched a compelling awareness and fundraising campaign with celebrity support including Seattle Seahawks head coach Pete Carroll and radio host Dave Ramsey.
By Cure SMA
Cure SMA, the leading organization dedicated to the treatment and cure of spinal muscular atrophy (SMA), recently provided an additional $445,000 grant toward a gene therapy for SMA at Nationwide Children’s Hospital.
12366896
By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ryan, Mary Ann Liebert, Inc., (914) 740-2100, kryan@liebertpub.com Pioneer Award Recipients Robin Ali, PhD, Jean Bennett, MD, PhD, and William Hauswirth, PhD Honored for Their Research on Gene Therapy in Eye Disorders New Rochelle,...
12349466
By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc, (914) 740-2100, kruehle@liebertpub.com Splice-Switching Oligonucleotide Therapeutics Is Promising New Method for Editing Gene Transcripts New Rochelle, NY—In splice-switching, an innovative therapeutic...
12340580
By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, Mary Ann Liebert, Inc, (914) 740-2100, ext. 2156, vcohn@liebertpub.com Frederic Bushman, PhD Receives Pioneer Award for Advancing Therapeutic Gene Delivery Methods New Rochelle, NY—Frederic D.
12317188
By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, Mary Ann Liebert, Inc, (914) 740-2100, ext. 2156, vcohn@liebertpub.com James Wilson, MD, PhD Receives Pioneer Award for Research on Gene Therapy and AAV Gene Delivery Systems New Rochelle, NY—James M.
12299634
By Mary Ann Liebert, Inc., publishers
Marina Cavazzana, MD, PhD, Paris Descartes University, and Adrian J. Thrasher, MD, PhD, University College London Institute of Child Health, have been honored with the Pioneer Award for basic and clinical gene therapy for immunodeficiency disorders.
12276341
By Mary Ann Liebert, Inc., publishers
for Developing First In Vivo Adenoviral Gene Delivery Vector
12264977
By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext.

All Press Releases

12554233
By Saving Case & Friends, Inc.
Efforts Bringing Awareness to Hunter Syndrome Are Recognized by Telly Awards and International Songwriting Competition
12474216
By Project Alive, a campaign of Saving Case & Friends
Parents of children with the rare disease Hunter Syndrome launched a compelling awareness and fundraising campaign with celebrity support including Seattle Seahawks head coach Pete Carroll and radio host Dave Ramsey.
By Foundation Care Pharmacy
Foundation Care Pharmacy, located in Earth City, MO, will be one of the pharmacies to provide cystic fibrosis patients with the new Vertex drug ORKAMBI™ (lumacaftor/ivacaftor).
By Roots Analysis
Roots Analysis has announced the addition of “Gene Therapy Market, 2015-2025” report to their offering. The market currently has only five approved therapies; of these, four are commercialised in geographies other than the US and EU.
By Cure SMA
Cure SMA, the leading organization dedicated to the treatment and cure of spinal muscular atrophy (SMA), recently provided an additional $445,000 grant toward a gene therapy for SMA at Nationwide Children’s Hospital.
By SMi Group Ltd
SMi’s BioBanking conference will be taking place on the 22 - 23 June 2015 at the Holiday Inn Regents Park Hotel in London, UK.
By Delveinsight Business Research LLP
DelveInsight a Market Research & Business Consulting firm has started a promotional offer on its Gene therapy reports highlighting their on-going demand across the globe.
By Visiongain
Visiongain’s new report predicts the world stem cell technologies market will reach $7.2bn in 2014. The overall industry will earn $12bn in 2018, achieving high revenue growth from 2015 to 2025.
By MoBiTec GmbH
Experience the transfection breakthrough. Achieve superior transfections with an innovative polymeric system that efficiently delivers both DNA and RNA out of the endosome and into the cytoplasm overcoming a critical barrier to nucleic acid delivery.
By Delveinsight Business Research LLP
Take Advantage of the very lucrative gene therapy market and play in the rare-air of the very few with DelveInsight’s Gene Therapy Reports!
12366896
By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ryan, Mary Ann Liebert, Inc., (914) 740-2100, kryan@liebertpub.com Pioneer Award Recipients Robin Ali, PhD, Jean Bennett, MD, PhD, and William Hauswirth, PhD Honored for Their Research on Gene Therapy in Eye Disorders New Rochelle,...
12349466
By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc, (914) 740-2100, kruehle@liebertpub.com Splice-Switching Oligonucleotide Therapeutics Is Promising New Method for Editing Gene Transcripts New Rochelle, NY—In splice-switching, an innovative therapeutic...
12340580
By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, Mary Ann Liebert, Inc, (914) 740-2100, ext. 2156, vcohn@liebertpub.com Frederic Bushman, PhD Receives Pioneer Award for Advancing Therapeutic Gene Delivery Methods New Rochelle, NY—Frederic D.
12317188
By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, Mary Ann Liebert, Inc, (914) 740-2100, ext. 2156, vcohn@liebertpub.com James Wilson, MD, PhD Receives Pioneer Award for Research on Gene Therapy and AAV Gene Delivery Systems New Rochelle, NY—James M.
12299634
By Mary Ann Liebert, Inc., publishers
Marina Cavazzana, MD, PhD, Paris Descartes University, and Adrian J. Thrasher, MD, PhD, University College London Institute of Child Health, have been honored with the Pioneer Award for basic and clinical gene therapy for immunodeficiency disorders.
By Mary Ann Liebert, Inc., publishers
Contact: Jennifer Quigley, Mary Ann Liebert, Inc, (914) 740-2100, ext.
By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, Mary Ann Liebert, Inc, (914) 740-2100 (914) 740-2100, ext. 2156, vcohn@liebertpub.com Joseph Glorioso, PhD Receives Pioneer Award for Engineering Herpes Simplex Virus Gene Delivery Systems New Rochelle, NY—Joseph C.
12276341
By Mary Ann Liebert, Inc., publishers
for Developing First In Vivo Adenoviral Gene Delivery Vector
12264977
By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext.
12254276
By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext.
By AveXis
Dallas, TX- AveXis-BioLife is pleased to announce the launch of the company’s brand new website: www.avexisinc.com.
By Mary Ann Liebert, Inc., publishers
The scientists who led the team that developed Glybera, the first gene therapy drug approved for use in the Western world, provide a fascinating first-person account of their pioneering work in Human Gene Therapy.
By Mary Ann Liebert, Inc., publishers
New Rochelle, NY, March 14, 2013—Severe chronic pain associated with conditions such as bladder pain syndrome/interstitial cystitis often require the use of opioid medication, with the risk of dependency and serious adverse reactions.
By Mary Ann Liebert, Inc., publishers
Follow-up results from one of several groundbreaking gene therapy studies reported in 2008 in patients with an inherited form of retinal blindness confirmed the earlier positive results of substantial improvement in vision.
By NTSAD
First human trial for Tay-Sachs, Canavan and other rare enzyme deficiency diseases plans to begin in early 2013 thanks to NTSAD, the nation's oldest patient advocacy organization, which leads efforts to find a cure or treatment.
By www.creativebiomart.net
After years of development and repeated rejections, uniQure finally got permission to market its gene therapy—Glybera.
By Mary Ann Liebert, Inc., publishers
The inaugural issue of BioResearch Open Access, a new bimonthly peer-reviewed open access journal, was released today by Mary Ann Liebert, Inc., publishers.
By Orion PR & Digital Pvt Ltd
Dr Agarwal’s Hospitals, announces a new technique in the world of Ophthalmology, done for the first time ever in the world “Autologous Retinal Transplant”.
By Mary Ann Liebert, Inc., publishers
BioResearch Open Access, a new bimonthly peer-reviewed open access journal, will launch in March 2012 by Mary Ann Liebert, Inc., publishers (www.liebertpub.com).
By Mary Ann Liebert, Inc., publishers
The time for commercial development of gene therapy has come. Patients with diseases treatable and curable with gene therapy deserve access to the technology.

Page:
Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share